文献速递创伤骨科关节外科

骨水泥与非骨水泥假体半髋置换术后48小时内死亡风险差异:大型国家登记研究Meta分析

Does the Risk of Death Within 48 Hours of Hip Hemiarthroplasty Differ Between Patients Treated with Cemented and Cementless Implants? A Meta-analysis of Large, National Registries.
PubMed 文献 · Clin Orthop Relat Res · 2022-01-01

该Meta分析纳入5项基于国家登记处的队列研究,比较骨水泥与非骨水泥半髋置换术后48小时内死亡风险。结果显示骨水泥组死亡风险显著增高(RR 1.63,95%CI 1.31-2.02;p<0.001),每183例骨水泥植入患者预期发生1例死亡。但作者指出非骨水泥假体与后期需再次手术的严重并发症相关,仅凭此研究不能推荐非骨水泥假体。

要点

  • 骨水泥半髋置换术后48小时内死亡风险是非骨水泥的1.63倍(95%CI 1.31-2.02)。
  • 每183例骨水泥植入患者预期增加1例死亡(NNH=1/183)。
  • 非骨水泥假体与后期需再次手术的严重并发症相关,可能间接导致死亡。

核心结论

  • 与免骨水泥假体相比,骨水泥与半髋置换术后48小时内死亡风险增高相关(RR 1.63,95%CI 1.31-2.02;p<0.001)。
  • 基于该研究 alone 不能推荐使用非骨水泥假体,因为既往研究提示非骨水泥装置与需额外手术的严重并发症相关,这些并发症也可能导致死亡。

研究设计与样本

  • 系统检索MEDLINE和Embase,纳入2010年后基于国家登记处的队列研究,比较骨水泥与非骨水泥半髋假体治疗髋部骨折后48小时内围手术期死亡。
  • 共纳入5项研究,队列规模约11,000至25,000例患者,其中约31%为免骨水泥组。
  • 研究质量按Newcastle-Ottawa量表评为良好;采用随机效应模型合并风险比(RR),并计算E值进行敏感性分析。

主要发现

  • 骨水泥组较免骨水泥组术后48小时内死亡风险增高(RR 1.63,95%CI 1.31-2.02;p<0.001)。
  • 合并数据需伤害人数(NNH)为每183例骨水泥植入患者预期发生1例死亡。
  • 研究间存在一定异质性(Cochran Q=8.13,df=4,p=0.08;I2=50.8%),Egger检验提示少量发表偏倚(p=0.02)。
  • 敏感性分析(E值)表明,未测量的混杂因素不太可能解释骨水泥与免骨水泥假体间48小时内死亡风险的显著关联。

关键数值与推荐

  • 纳入标准:基于国家登记处、报告术后48小时内围手术期死亡、2010年或之后发表、使用当代骨水泥技术的队列研究。
  • 排除标准:择期全髋关节置换术(THA)的其他适应症研究、混合人群无法分离骨折与其他诊断的研究、同一登记处的重叠数据。
  • 主要终点:比较骨水泥与免骨水泥假体半髋置换术后48小时内任何原因死亡的发生率。

临床怎么用

  • 临床选择半髋置换假体固定方式时,应权衡骨水泥相关的早期死亡风险(每183例约1例)与非骨水泥假体相关的后期需再次手术的严重并发症风险。
  • 该研究结果不支持仅基于早期死亡风险而常规推荐免骨水泥假体;需结合患者个体情况和登记数据综合决策。

局限性

  • 研究间存在一定异质性(I2=50.8%),且Egger检验提示少量发表偏倚(p=0.02)。
  • 仅纳入5项国家登记研究,部分研究未报告年龄范围、麻醉分级等基线细节。
  • 不能排除未测量混杂因素的影响,尽管E值分析提示其不太可能解释主要结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although current recommendations suggest that hip hemiarthroplasties performed for femoral neck fractures be implanted with bone cement, it is known to cause cardiorespiratory and hemodynamic reactions that in some patients can be fatal. Older patients may be at particular risk of this complication, but because of its relative infrequency, large studies-perhaps even larger than can be achieved in the context of single-country national registries-are needed to get reasonably precise estimates as to its frequency. Pooling results from national registries reporting on death within 48 hours of cement exposure in this setting may therefore be helpful. QUESTION/PURPOSE: In a systematic review of studies based on large national registries, we asked: Does the risk of death within 48 hours of hip hemiarthroplasty differ between patients treated with cemented and cementless implants? METHODS: MEDLINE and Embase data sources were searched for cohort studies on patients with hip fractures treated with cement or cementless hip hemiprostheses based on results from national registries that tracked perioperative deaths within 48 hours of surgery, from 2010 or later (to include only studies that used contemporary cement techniques). We excluded registry research on elective THAs for other indications (such as degenerative joint disease), mixed populations (registries that combined patients having arthroplasty for fracture and for other diagnoses like osteoarthritis, such that we could not separate them), and overlapping data from the same registers (to avoid double and triple publications of similar data). Five studies met our inclusion criteria. The cohorts ranged from about 11,000 to about 25,000 patients. About 31% of the patients were in the cementless group. Two studies reported the age ranges of participating patients, and three studies communicated mean ages (which were 82 years for both sexes). Twice as many females as males were present in both the cemented and cementless group. When reported, more than 50% in both groups were in the American Society of Anesthesiologists physical status classification 3 or 4. Study quality was deemed good according to the Newcastle-Ottawa Scale. Publication bias was assessed using a funnel plot and the Egger test, and study heterogeneity was evaluated using the I2 heterogeneity statistic and Cochran Q heterogeneity test. There was some heterogeneity between the studies, with a Cochran Q statistics of 8.13 (degrees of freedom = 4; p = 0.08) and an I2 statistic of 50.8%. There was evidence for a small amount of publication bias (Egger test; p = 0.02). The pooled risk ratio (RR) from a random-effects model is presented with 95% confidence intervals. The primary endpoint was the occurrence of any fatalities within 48 hours of hip fracture treatment with cementless compared with cemented prostheses. We performed a sensitivity analysis to assess the needed association of a potential unmeasured or uncontrolled confounding, and we made an estimate of the amount of unmeasured confounding that would need to be present in order to change the direction of the result. We summarized this using a parameter known as the "E-value." Based on that sensitivity analysis, we found it unlikely that an unmeasured hypothetical confounder could explain the significant association between cemented and cementless implants and risk of death within 48 hours of hip hemiarthroplasty. RESULTS: Compared with the cementless group, mortality was increased in the cemented group (RR 1.63 [95% CI 1.31 to 2.02]; p < 0.001). The number needed to harm from the pooled data was 1 of 183 operated patients; that is, for every 183 patients treated with cemented implants, one death would be expected. CONCLUSION: Bone cement is associated with a higher risk of fatalities within 48 hours of surgery compared with cementless prostheses. However, numerous prior studies have found a higher risk of serious complications resulting in additional surgical procedures associated with cementless devices in this population; those complications, as well, may result in death. Based on our study alone, we cannot recommend cementless implants in this setting. Large, national registries should evaluate fixation choice in older patients with hip fractures, and those studies should consider both early death and the potential for later harms. LEVEL OF EVIDENCE: Level III, therapeutic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Dahl OE, Pripp AH. Does the Risk of Death Within 48 Hours of Hip Hemiarthroplasty Differ Between Patients Treated with Cemented and Cementless Implants? A Meta-analysis of Large, National Registries. Clin Orthop Relat Res. 2022. PMID: 34491939. doi:10.1097/CORR.0000000000001952

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。